Hermosilla, Manuel - 2019
We study the drug licensing behavior (acquisition of rights for developing drugs) of large pharmaceutical firms in the … aftermath of large negative shocks to their pipelines, Phase 3 failures (P3Fs). We find that P3Fs lead to increased licensing … within a year of the event. This result is significant because one year is a short window given the usual timelines---licensing …